What is already known about this topic?
Pneumoconioses are a group of occupational lung diseases caused by inhaling organic dust and inorganic mineral dust particles. From 1968 to 2000, death rates for all pneumoconioses decreased with the exception of those for asbestosis. Although preventable, deaths continue to occur.
What is added by this report?
Pneumoconiosis deaths decreased from 2,738 deaths in 1999 to 1,632 in 2018, and age-adjusted death rates decreased from 12.8 to 5.3 per million population. All pneumoconioses decreased with the exception of pneumoconiosis attributed to other inorganic dusts.
What are the implications for public health practice?
Pneumoconiosis-associated deaths continue to occur, underscoring the importance of occupational dust exposure reduction, early case detection, and continued surveillance to monitor trends, with an increased focus on pneumoconiosis attributable to other inorganic dusts.
Pneumoconioses are preventable occupational lung diseases caused by inhaling dust particles such as coal dust or different types of mineral dusts (1). To assess recent trends in deaths associated with pneumoconiosis, CDC analyzed multiple cause-of-death data*,† for decedents aged ≥15 years for the years 1999–2018, and industry and occupation data collected from 26 states§ for the years 1999, 2003, 2004, and 2007–2013. During 1999–2018, pneumoconiosis deaths decreased by 40.4%, with the exception of pneumoconiosis attributed to other inorganic dusts (e.g., aluminum, bauxite, beryllium, iron, and tin oxide), which increased significantly (p-value for time trend <0.05). The largest observed decreases in pneumoconiosis deaths were for those associated with coal workers' pneumoconiosis (69.6%) and silicosis (53.0%). Asbestosis was the most frequently reported pneumoconiosis and was associated with working in the construction industry. The ongoing occurrence of deaths associated with pneumoconiosis underscores the importance of occupational dust exposure reduction, early case detection, and continued surveillance to monitor trends.
Read full from:
https://www.cdc.gov/mmwr/volumes/69/wr/mm6923a1.htm
Pneumoconioses are a group of occupational lung diseases caused by inhaling organic dust and inorganic mineral dust particles. From 1968 to 2000, death rates for all pneumoconioses decreased with the exception of those for asbestosis. Although preventable, deaths continue to occur.
What is added by this report?
Pneumoconiosis deaths decreased from 2,738 deaths in 1999 to 1,632 in 2018, and age-adjusted death rates decreased from 12.8 to 5.3 per million population. All pneumoconioses decreased with the exception of pneumoconiosis attributed to other inorganic dusts.
What are the implications for public health practice?
Pneumoconiosis-associated deaths continue to occur, underscoring the importance of occupational dust exposure reduction, early case detection, and continued surveillance to monitor trends, with an increased focus on pneumoconiosis attributable to other inorganic dusts.
Pneumoconioses are preventable occupational lung diseases caused by inhaling dust particles such as coal dust or different types of mineral dusts (1). To assess recent trends in deaths associated with pneumoconiosis, CDC analyzed multiple cause-of-death data*,† for decedents aged ≥15 years for the years 1999–2018, and industry and occupation data collected from 26 states§ for the years 1999, 2003, 2004, and 2007–2013. During 1999–2018, pneumoconiosis deaths decreased by 40.4%, with the exception of pneumoconiosis attributed to other inorganic dusts (e.g., aluminum, bauxite, beryllium, iron, and tin oxide), which increased significantly (p-value for time trend <0.05). The largest observed decreases in pneumoconiosis deaths were for those associated with coal workers' pneumoconiosis (69.6%) and silicosis (53.0%). Asbestosis was the most frequently reported pneumoconiosis and was associated with working in the construction industry. The ongoing occurrence of deaths associated with pneumoconiosis underscores the importance of occupational dust exposure reduction, early case detection, and continued surveillance to monitor trends.
Read full from:
https://www.cdc.gov/mmwr/volumes/69/wr/mm6923a1.htm
